Urology
 |
|
4 february 2019 12:59:44 |
| Reply to Joe O`Sullivan, Daniel Heinrich, Nicholas D. James, et al.`s Letter to the Editor re: The Case Against the European Medicines Agency`s Change to the Label for Radium-223 for the Treatment of Metastatic Castration-resistant Prostate Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2018.11.003 (European Urology) |
|
Tweet EMA welcomes this opportunity to comment on the letter from O`Sullivan et al. [1] regarding the recommendation of the European Medicines Agency (EMA) on Xofigo (radium-223 dichloride). |
| 67 viewsCategory: Urology |
 The Microbiome and Genitourinary Cancer: A Collaborative Review (European Urology)A Return to the Days of Radical Nephrectomy as the `Gold Standard` for Localized Renal Cell Carcinoma? Not So Fast (European Urology) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page